Sulfur and oxygen isotope characterization of an Eocene playa deposit, northern High Plains, and rainwater sulfate, Baton Rouge, USA

This thesis is composed of two independent chapters which are linked through the application of multiple stable isotope measurements of sulfate. Chapter 1 compares two Cenozoic playa deposits in the northern High Plains. Anomalous playa sulfate was discovered at Scotts Bluff which is speculated to have originated via the oxidation of volcanically emitted reduced sulfur gases. A question arises, then, is a volcanic origin of sulfate common for other Cenozoic playa deposits in the region. A complete stable isotope characterization was performed on the gypsum sulfate collected at Wolf Butte (nearby apparent playa setting) to determine if the sulfate has a similar origin to that in the Scotts Bluff playa. No17O anomaly was found in the sulfate at Wolf Butte and the δ34S values range from +12.2 to +14.8‰. Potential sources of sulfate at Wolf Butte include weathering of Cretaceous shale and leaching of volcanic ashes. It is concluded that Scotts Bluff and Wolf Butte represent two different playa gypsum deposits that existed during the Cenozoic in the High Plains. Chapter 2 looks into atmospheric chemical reactions that form tropospheric sulfate in Baton Rouge area. Multiple stable isotope compositions of atmospheric sulfate in La Jolla, California (Lee 2001) revealed competing oxidation pathways exist between ozone (O3) and hydrogen peroxide (H2O2). To elucidate the source and origin of atmospheric sulfate in Baton Rouge air shed, oxygen and sulfur isotopic compositions were analyzed. The outcome of this survey found that the sulfate isotopic composition data range from 0.25 to 1.43‰ and 11.8 to 19.3‰ for ∆17O and δ18O, respectively, and -1.4 to 3.8‰ for δ34S. High ∆17O values were not favored in the winter season as was seen in the study preformed in California (Lee 2001). The sulfate δ34S appear to be slightly depleted with respect to those in La Jolla rainwater and may be due to a predominately anthropogenic (δ34S~0‰) rather than marine (δ34S~+9.9‰ ±6‰) source of sulfate. Also, sulfate concentrations in rainwater were more than twice that measured in two nearby Louisiana monitoring stations, which may be due to the sampling site’s close proximity to oil refinery facilities

The passage of the bomb radiocarbon pulse into the Pacific Ocean

Author Posting. © Arizona Board of Regents on behalf of the University of Arizona, 2010. This article is posted here by permission of Dept. of Geosciences, University of Arizona for personal use, not for redistribution. The definitive version was published in Radiocarbon 52 (2010): 1182-1190.We report and compare radiocarbon observations made on 2 meridional oceanographic sections along 150°W in the South Pacific in 1991 and 2005. The distributions reflect the progressive penetration of nuclear weapons-produced 14C into the oceanic thermocline. The changes over the 14 yr between occupations are demonstrably large relative to any possible drift in our analytical standardization. The computed difference field based on the gridded data in the upper 1600 m of the section exhibits a significant decrease over time (approaching 40 to 50‰ in Δ14C) in the upper 200–300 m, consistent with the decadal post-bomb decline in atmospheric 14C levels. A strong positive anomaly (increase with time), centered on the low salinity core of the Antarctic Intermediate Water (AAIW), approaches 50–60‰ in Δ14C, a clear signature of the downstream evolution of the 14C transient in this water mass. We use this observation to estimate the transit time of AAIW from its “source region” in the southeast South Pacific and to compute the effective reservoir age of this water mass. The 2 sections show small but significant changes in the abyssal 14C distributions. Between 1991 and 2005, Δ14C has increased by 9‰ below 2000 m north of 55°S. This change is accompanied overall by a modest increase in salinity and dissolved oxygen, as well as a slight decrease in dissolved silica. Such changes are indicative of greater ventilation. Calculation of “phosphate star” also indicates that this may be due to a shift from the Southern Ocean toward North Atlantic Deep Water as the ventilation source of the abyssal South Pacific.This work was performed under National Science Foundation Grant number OCE-0223434 as well as a cooperative agreement with NSF (most recently OCE-0228996)

A high-performance 14C accelerator mass spectrometry system

Author Posting. © Arizona Board of Regents on behalf of the University of Arizona, 2010. This article is posted here by permission of Dept. of Geosciences, University of Arizona for personal use, not for redistribution. The definitive version was published in Radiocarbon 52 (2010): 228-235.A new and unique radiocarbon accelerator mass spectrometry (AMS) facility has been constructed at the Woods Hole Oceanographic Institution. The defining characteristic of the new system is its large-gap optical elements that provide a larger-than-standard beam acceptance. Such a system is ideally suited for high-throughput, high-precision measurements of 14C. Details and performance of the new system are presented

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

PrefHer revealed compelling and consistent patient preference for subcutaneous (s.c.) trastuzumab, regardless of delivery by single-use injection device or hand-held syringe. s.c. trastuzumab was well-tolerated and safety data, including immunogenicity, were consistent with previous reports. No new safety signals were identified compared with the known intravenous trastuzumab profile in early breast cance

The Marine Microbial Eukaryote Transcriptome Sequencing Project (MMETSP): illuminating the functional diversity of eukaryotic life in the oceans through transcriptome sequencing

International audienceCurrent sampling of genomic sequence data from eukaryotes is relatively poor, biased, and inadequate to address important questions about their biology, evolution, and ecology; this Community Page describes a resource of 700 transcriptomes from marine microbial eukaryotes to help understand their role in the world's oceans

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.

BACKGROUND: Staphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, or death, by enhancing early S aureus killing, sterilising infected foci and blood faster, and reducing risks of dissemination and metastatic infection. METHODS: In this multicentre, randomised, double-blind, placebo-controlled trial, adults (≥18 years) with S aureus bacteraemia who had received ≤96 h of active antibiotic therapy were recruited from 29 UK hospitals. Patients were randomly assigned (1:1) via a computer-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, together with standard antibiotic therapy. Randomisation was stratified by centre. Patients, investigators, and those caring for the patients were masked to group allocation. The primary outcome was time to bacteriologically confirmed treatment failure or disease recurrence, or death (all-cause), from randomisation to 12 weeks, adjudicated by an independent review committee masked to the treatment. Analysis was intention to treat. This trial was registered, number ISRCTN37666216, and is closed to new participants. FINDINGS: Between Dec 10, 2012, and Oct 25, 2016, 758 eligible participants were randomly assigned: 370 to rifampicin and 388 to placebo. 485 (64%) participants had community-acquired S aureus infections, and 132 (17%) had nosocomial S aureus infections. 47 (6%) had meticillin-resistant infections. 301 (40%) participants had an initial deep infection focus. Standard antibiotics were given for 29 (IQR 18-45) days; 619 (82%) participants received flucloxacillin. By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or disease recurrence, or died (absolute risk difference -1·4%, 95% CI -7·0 to 4·3; hazard ratio 0·96, 0·68-1·35, p=0·81). From randomisation to 12 weeks, no evidence of differences in serious (p=0·17) or grade 3-4 (p=0·36) adverse events were observed; however, 63 (17%) participants in the rifampicin group versus 39 (10%) in the placebo group had antibiotic or trial drug-modifying adverse events (p=0·004), and 24 (6%) versus six (2%) had drug interactions (p=0·0005). INTERPRETATION: Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia. FUNDING: UK National Institute for Health Research Health Technology Assessment

Shared heritability and functional enrichment across six solid cancers

Correction: Nature Communications 10 (2019): art. 4386 DOI: 10.1038/s41467-019-12095-8Quantifying the genetic correlation between cancers can provide important insights into the mechanisms driving cancer etiology. Using genome-wide association study summary statistics across six cancer types based on a total of 296,215 cases and 301,319 controls of European ancestry, here we estimate the pair-wise genetic correlations between breast, colorectal, head/neck, lung, ovary and prostate cancer, and between cancers and 38 other diseases. We observed statistically significant genetic correlations between lung and head/neck cancer (r(g) = 0.57, p = 4.6 x 10(-8)), breast and ovarian cancer (r(g) = 0.24, p = 7 x 10(-5)), breast and lung cancer (r(g) = 0.18, p = 1.5 x 10(-6)) and breast and colorectal cancer (r(g) = 0.15, p = 1.1 x 10(-4)). We also found that multiple cancers are genetically correlated with non-cancer traits including smoking, psychiatric diseases and metabolic characteristics. Functional enrichment analysis revealed a significant excess contribution of conserved and regulatory regions to cancer heritability. Our comprehensive analysis of cross-cancer heritability suggests that solid tumors arising across tissues share in part a common germline genetic basis.Peer reviewe